… gold standard treatment for upper tract urothelial carcinoma (… for UT-CIS, our results confirm
that BCG instillations are also … 1 ml per minute to avoid intrarenal tension. BCG solution was …

… to avoid intrarenal tension. … upper tract urothelial carcinoma in situ (Patient) managed with
endocavitary BCG instillation (Intervention) to analyze the oncological outcomes (Outcome) in …

… We report the outcomes of patients treated with endoluminal … The final cohort included 53
patients with 65 upper tract units; 31 … Presenting pathology included biopsy-proven CIS and HG …

… We reviewed the current literature on the epidemiology, disease characteristics, treatment,
and outcomes of UTUC with a particularly focus on intraluminal adjuvant therapy for UTUC. …

… Our understanding of this entity in the upper tract is … outcomes of BCG therapy in BCIS.24,
25 However, to our knowledge the feasibility of delivering prolonged therapy to the upper tract …

… reduce recurrence, but delivery to the upper tract is more challenging than into the bladder.
… Outcomes of intrarenal Bacillus CalmetteGuérin/interferon-α2B for biopsy-proven upper-tract …

… upper tract instillations in superficial upper tract urothelial carcinoma remains to be
demonstrated, upcoming novel drugs and instillation approaches have to challenge these results. …

… trial of UGN-101 for primary or recurrent biopsy-proven low-grade UTUC. Of the 71 patients
… [46] reported the results of robot-assisted mini-endoscopic combined with intrarenal surgery …

… Outcomes of intrarenal Bacillus Calmette-Guérin/interferon-α2B for biopsy-proven upper-tract
carcinoma in situ. J Endourol. 2012 Dec;26(12):1645–50. …

… upper tract CIS (UTCIS) with the goal of delving into diagnosis, pathologic interpretation,
treatment algorithms, and survival outcomes. A … understand disease outcomes particularly when …